Access Pharmaceuticals' CEO Kerry Gray Talks to The Wall Street Transcript.Business Editors NEW YORK--(BUSINESS WIRE)--Aug. 14, 2000 The Wall Street Transcript A generic term for any kind of copy, particularly an official or certified representation of the record of what took place in a court during a trial or other legal proceeding. A transcript of record has published an in-depth in-depth adj. Detailed; thorough: an in-depth study. in-depth Adjective detailed or thorough: an in-depth analysis interview with Kerry Gray, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Access Pharmaceuticals (AMEX AMEX See: American Stock Exchange :AKC AKC - Ascending Kleene Chain ), in which he talks at length about the company's future. The entire 3,200-word interview is available free online at http://www.twst.com/ceos.htm Gray gives an overview of the company. "Our primary customer is the mid to large pharmaceutical companies, where it is our objective to provide value-added products to these customers for ultimate marketing to the end user. At this point in time, it is not in our business strategy to have our own sales and marketing organization. We are more of a development company, as compared to a fully integrated company." Gray explains, "We try to maintain a balance of low-, medium- and high-risk high-risk adjective Referring to an ↑ risk of suffering from a particular condition Infectious disease Referring to an ↑ risk for exposure to blood-borne pathogens, which occurs with blood bank technicians, dental professionals, dialysis unit projects. Generally, the higher the risk, the greater the potential reward. But we do have some ongoing lower risk projects, which are also very significant market opportunities. Obviously, that's a place you want to be. We've also looked at reducing our financial risk by adopting a strategy where we don't intend to be a fully integrated company. We do not perform basic research in the company." Looking forward, Gray states, "I would anticipate that the movement toward consolidation in all sectors -- large pharma, the emerging pharmaceutical and the biotechnology sector -- to continue at an accelerated rate. We have gone about establishing this company to take advantage of that situation. I have always believed that there are far too many smaller companies and that one management group could effectively develop numerous technologies. Access has been established by accumulating technologies and companies, putting them under the one management entity, and then leveraging that management entity across those technologies." This interview is part of a 114-page Global Healthcare Investments in Biotechnology and Pharmaceuticals Issue available at http://www.twst.com/info/info152.htm or by calling 212/952-7433 The Wall Street Transcript is a premier weekly investment publication serving serious long-term investors Long-term investor A person who makes investments for a period of at least five years in order to finance his or her long-term goals. for over 37 years. The Wall Street Transcript has launched a new free service where investors can ask Access Pharmaceuticals (or any public company) a question at http://www.qawire.com The Wall Street Transcript does not endorse To sign a paper or document, thereby making it possible for the rights represented therein to pass to another individual. Also spelled indorse. endorse (indorse) v. the views of any interviewees nor does it make stock recommendations. For subscription information call 800/246-7673. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion